VEGF activator zinc finger protein

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameVEGF activator zinc finger protein
Drug Alias Name血管内皮生长因子激活物锌指蛋白hVEGF-ASB-509
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transferenceVascular endothelial growth factor A stimulantsAngiogenesis inducers
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Macular Edema +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMexico +[6] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSangamo Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSangamo Therapeutics IncRegeneron Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Macular Edema +[5] 

Other Information

ATC CodeN/A
Related LinksN/A